BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 35432323)

  • 1. Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation.
    Li H; Cao Z; Wang L; Liu C; Lin H; Tang Y; Yao P
    Front Immunol; 2022; 13():843712. PubMed ID: 35432323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological relevance of macrophage subsets in atherogenesis.
    Liberale L; Dallegri F; Montecucco F; Carbone F
    Thromb Haemost; 2017 Jan; 117(1):7-18. PubMed ID: 27683760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversity of macrophage phenotypes and responses in atherosclerosis.
    Jinnouchi H; Guo L; Sakamoto A; Torii S; Sato Y; Cornelissen A; Kuntz S; Paek KH; Fernandez R; Fuller D; Gadhoke N; Surve D; Romero M; Kolodgie FD; Virmani R; Finn AV
    Cell Mol Life Sci; 2020 May; 77(10):1919-1932. PubMed ID: 31720740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Macrophage activation in atherosclerosis. Message 1: Activation of macrophages normally and in atherosclerotic lesions].
    Nikiforov NG; Kornienko VY; Karagodin VP; Orekhov AN
    Patol Fiziol Eksp Ter; 2015; (3):128-31. PubMed ID: 26852607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage phenotypes in atherosclerosis.
    Colin S; Chinetti-Gbaguidi G; Staels B
    Immunol Rev; 2014 Nov; 262(1):153-66. PubMed ID: 25319333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting foam cell formation and macrophage polarization in atherosclerosis: The Therapeutic potential of rhubarb.
    Liu X; Wu J; Tian R; Su S; Deng S; Meng X
    Biomed Pharmacother; 2020 Sep; 129():110433. PubMed ID: 32768936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage profiling in atherosclerosis: understanding the unstable plaque.
    Gianopoulos I; Daskalopoulou SS
    Basic Res Cardiol; 2024 Feb; 119(1):35-56. PubMed ID: 38244055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in transcriptome of macrophages in atherosclerosis.
    Chistiakov DA; Bobryshev YV; Orekhov AN
    J Cell Mol Med; 2015 Jun; 19(6):1163-73. PubMed ID: 25973901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
    McLaren JE; Michael DR; Ashlin TG; Ramji DP
    Prog Lipid Res; 2011 Oct; 50(4):331-47. PubMed ID: 21601592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage polarisation associated with atherosclerosis differentially affects their capacity to handle lipids.
    Baidžajevas K; Hadadi É; Lee B; Lum J; Shihui F; Sudbery I; Kiss-Tóth E; Wong SC; Wilson HL
    Atherosclerosis; 2020 Jul; 305():10-18. PubMed ID: 32592946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherogenic lipids and macrophage subsets.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2015 Oct; 26(5):357-61. PubMed ID: 26218415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy.
    Momtazi-Borojeni AA; Abdollahi E; Nikfar B; Chaichian S; Ekhlasi-Hundrieser M
    Heart Fail Rev; 2019 May; 24(3):399-409. PubMed ID: 30673930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage Polarization in Atherosclerosis.
    Eshghjoo S; Kim DM; Jayaraman A; Sun Y; Alaniz RC
    Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL4-induced macrophages in human atherosclerosis.
    Domschke G; Gleissner CA
    Cytokine; 2019 Oct; 122():154141. PubMed ID: 28899579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis.
    Gong M; Zhuo X; Ma A
    Med Sci Monit Basic Res; 2017 Jun; 23():240-249. PubMed ID: 28615615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques.
    Finn AV; Nakano M; Polavarapu R; Karmali V; Saeed O; Zhao X; Yazdani S; Otsuka F; Davis T; Habib A; Narula J; Kolodgie FD; Virmani R
    J Am Coll Cardiol; 2012 Jan; 59(2):166-77. PubMed ID: 22154776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage death in atherosclerosis: potential role in calcification.
    Neels JG; Gollentz C; Chinetti G
    Front Immunol; 2023; 14():1215612. PubMed ID: 37469518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD163 deficiency increases foam cell formation and plaque progression in atherosclerotic mice.
    Gutiérrez-Muñoz C; Méndez-Barbero N; Svendsen P; Sastre C; Fernández-Laso V; Quesada P; Egido J; Escolá-Gil JC; Martín-Ventura JL; Moestrup SK; Blanco-Colio LM
    FASEB J; 2020 Nov; 34(11):14960-14976. PubMed ID: 32924185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation.
    Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of metabolic reprogramming of oxygen-induced macrophages in the dynamic changes of atherosclerotic plaques.
    Shen L; Chen W; Ding J; Shu G; Chen M; Zhao Z; Xia S; Ji J
    FASEB J; 2023 Mar; 37(3):e22791. PubMed ID: 36723768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.